PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PharmaSGP Holding SE (PSG.DE)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

DE000A2P4LJ5

Sector

Healthcare

Highlights

Market Cap

€297.36M

EPS (TTM)

€1.52

PE Ratio

16.32

Total Revenue (TTM)

€88.58M

Gross Profit (TTM)

€76.34M

EBITDA (TTM)

€28.28M

Year Range

€18.68 - €28.00

Target Price

€38.80

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
PSG.DE vs. ARCC
Popular comparisons:
PSG.DE vs. ARCC

Performance

Performance Chart

The chart shows the growth of an initial investment of €10,000 in PharmaSGP Holding SE, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-10.00%0.00%10.00%20.00%30.00%SeptemberOctoberNovemberDecember2025February
26.92%
15.68%
PSG.DE (PharmaSGP Holding SE)
Benchmark (^GSPC)

Returns By Period

PharmaSGP Holding SE had a return of 8.20% year-to-date (YTD) and 25.83% in the last 12 months.


PSG.DE

YTD

8.20%

1M

1.54%

6M

26.92%

1Y

25.83%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

3.96%

1M

2.77%

6M

10.09%

1Y

21.57%

5Y*

12.62%

10Y*

11.30%

*Annualized

Monthly Returns

The table below presents the monthly returns of PSG.DE, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20259.02%8.20%
2024-5.33%4.69%-1.79%6.85%-4.27%10.08%-9.48%-2.86%0.98%19.42%3.25%-3.94%15.26%
2023-3.01%0.78%11.15%-0.00%-7.27%5.25%-2.17%-11.44%0.00%-16.25%-6.72%20.00%-13.86%
2022-5.26%-2.99%-4.85%11.11%-0.00%-0.22%2.55%7.05%-3.10%-0.00%-1.60%8.13%9.74%
2021-16.35%-2.30%-5.98%-17.42%40.00%-0.43%3.91%0.42%-8.75%12.79%5.26%-5.00%-5.00%
2020-7.97%-5.51%3.00%1.29%-5.75%-14.41%2.97%-24.64%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of PSG.DE is 71, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of PSG.DE is 7171
Overall Rank
The Sharpe Ratio Rank of PSG.DE is 7373
Sharpe Ratio Rank
The Sortino Ratio Rank of PSG.DE is 6868
Sortino Ratio Rank
The Omega Ratio Rank of PSG.DE is 6464
Omega Ratio Rank
The Calmar Ratio Rank of PSG.DE is 7373
Calmar Ratio Rank
The Martin Ratio Rank of PSG.DE is 7777
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for PharmaSGP Holding SE (PSG.DE) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for PSG.DE, currently valued at 0.84, compared to the broader market-2.000.002.004.000.841.83
The chart of Sortino ratio for PSG.DE, currently valued at 1.40, compared to the broader market-6.00-4.00-2.000.002.004.006.001.402.47
The chart of Omega ratio for PSG.DE, currently valued at 1.17, compared to the broader market0.501.001.502.001.171.33
The chart of Calmar ratio for PSG.DE, currently valued at 0.76, compared to the broader market0.002.004.006.000.762.76
The chart of Martin ratio for PSG.DE, currently valued at 4.21, compared to the broader market-10.000.0010.0020.0030.004.2111.27
PSG.DE
^GSPC

The current PharmaSGP Holding SE Sharpe ratio is 0.84. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of PharmaSGP Holding SE with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
0.84
1.94
PSG.DE (PharmaSGP Holding SE)
Benchmark (^GSPC)

Dividends

Dividend History

PharmaSGP Holding SE provided a 5.15% dividend yield over the last twelve months, with an annual payout of €1.36 per share. The company has been increasing its dividends for 2 consecutive years.


2.00%3.00%4.00%5.00%6.00%€0.00€0.20€0.40€0.60€0.80€1.00€1.20€1.40202220232024
Dividends
Dividend Yield
PeriodTTM202420232022
Dividend€1.36€1.36€0.49€0.45

Dividend yield

5.15%5.57%2.18%1.69%

Monthly Dividends

The table displays the monthly dividend distributions for PharmaSGP Holding SE. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025€0.00€0.00€0.00
2024€0.00€0.00€0.00€0.00€0.00€1.36€0.00€0.00€0.00€0.00€0.00€0.00€1.36
2023€0.00€0.00€0.00€0.00€0.00€0.49€0.00€0.00€0.00€0.00€0.00€0.00€0.49
2022€0.45€0.00€0.00€0.00€0.00€0.00€0.00€0.45

Dividend Yield & Payout


Dividend Yield
100.0%200.0%300.0%400.0%500.0%600.0%5.2%
PharmaSGP Holding SE has a dividend yield of 5.15%, which is quite average when compared to the overall market.
Payout Ratio
200.0%400.0%600.0%800.0%118.3%
PharmaSGP Holding SE has a payout ratio of 118.31%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-15.60%
-1.01%
PSG.DE (PharmaSGP Holding SE)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the PharmaSGP Holding SE. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the PharmaSGP Holding SE was 54.49%, occurring on May 5, 2021. The portfolio has not yet recovered.

The current PharmaSGP Holding SE drawdown is 15.60%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-54.49%Jun 22, 2020221May 5, 2021

Volatility

Volatility Chart

The current PharmaSGP Holding SE volatility is 8.86%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%16.00%SeptemberOctoberNovemberDecember2025February
8.86%
3.50%
PSG.DE (PharmaSGP Holding SE)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of PharmaSGP Holding SE over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for PharmaSGP Holding SE.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab